The global healthcare system is a large contributor to greenhouse gas emissions, representing 4.4% of the total worldwide footprint.[1] Supply chains occupy a significant share of this contribution. In the UK, for instance, 62% of the National Health Service’s emissions footprint came from the supply chain in 2019. [2] The purchasing power of healthcare systems […]
The NIH Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative Cell Census Network (BICCN) [1] has unveiled an atlas of cell types and an anatomical neuronal wiring diagramme for the mammalian primary motor cortex, derived from detailed studies of mice, monkeys, and humans. This publicly available resource represents the culmination of an international collaborative effort […]
Scientists pave the way for reducing the harmful side effects antibiotics have on gut bacteria
A Tel Aviv, Israel-based tech company has built a surgical robot that is worth a billion dollars.
Paris, France-based Ganymed Robotics, a start-up developer of advanced software and robotics technologies for orthopaedic surgeons, has secured a €2,5 million grant through the European Innovation Council (EIC) Accelerator program. The company says it will use the EIC funding to accelerate product development and further strengthen its team, to become global category leader in surgical […]
In a laudable initiative to advance health equity, Cerner Corporation, working at the intersection of healthcare and information technology, has recently launched a new solution called Cerner Determinants of Health.
Recently published research [1] provides new hope for a potential cure for the devastating cystic fibrosis disease. In the study, a research collaboration demonstrated how they corrected mutations that cause cystic fibrosis in cultured human stem cells using a CRISPR/Cas9 variant technique called prime editing to replace the ‘faulty’ piece of DNA with a healthy […]
As a partner of the Fraunhofer Competence Network Quantum Computing, the German Cancer Research Center is planning to use the quantu m computer in Ehningen, Baden-Württemberg, to develop individually effective cancer treatment methods.
DeepMind has partnered with the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory for the life sciences, to make the most complete and accurate database yet of predicted protein structure models for the human proteome.
Personalized tumour treatments are expensive. This particularly applies to individual cancer therapies based on gene-modified T cells. Currently, they are produced manually or, at best, in a partially automated process. In a collaboration project “ProCell for Patient” two hospitals are currently working with Optima Pharma to develop an automated unit for the decentralized production of […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
